Insights from ELCC 2024
ELCC 2024 Insights: "ETOP ABC-Lung Trial - Atezo + Bev & Chemo in EGFRm NSCLC With Acquired Resistance"
By
Insights from ELCC 2024
FEATURING
Martin Früh
By
Insights from ELCC 2024
FEATURING
Martin Früh
Comments 0
Login to view comments.
Click here to Login
